Trial intelligence / Profile preview

Aspirin Responsiveness in Women at Risk for Cardiac Events

NCT00818337Phase 4Completed

Sponsor
Creighton University
Start
Nov 2008
Primary completion
Jun 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of aspirin in cardiovascular disease (CVD), sponsored by Creighton University. Started Nov 2008; status: completed.

02

Drugs

aspirin
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT00818337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00818337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call